The clinical importance of these observations may be significant as therapy for medulloblastoma has remained largely unchanged for the last 20 years, and concerns about therapy-related late toxicities have prompted systematic attempts at treatment deintensification.
← all excerpts
Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiotherapy.
1
—
—